Jeffery Chadbourne - IDEXX Laboratories Director Reporting
| IX1 Stock | EUR 406.20 6.80 1.70% |
Insider
Jeffery Chadbourne is Director Reporting of IDEXX Laboratories
| Age | 47 |
| Phone | 207 556 0300 |
| Web | https://www.idexx.com |
IDEXX Laboratories Management Efficiency
The company has return on total asset (ROA) of 0.2167 % which means that it generated a profit of $0.2167 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 1.0458 %, meaning that it generated $1.0458 on every $100 dollars invested by stockholders. IDEXX Laboratories' management efficiency ratios could be used to measure how well IDEXX Laboratories manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Jennifer Honeycutt | Danaher | 53 | |
| Joakim Weidemanis | Danaher | 54 | |
| Jan Wicke | Talanx AG | 55 | |
| Harry Kanwar | Superior Plus Corp | N/A | |
| Caroline Schlienkamp | Talanx AG | 49 | |
| Eivind Kallevik | Norsk Hydro ASA | 56 | |
| Steven Humphreys | Identiv | 62 | |
| Wilm Langenbach | Talanx AG | 52 | |
| Amir Khoshniyati | Identiv | N/A | |
| JeanJacques Henchoz | Talanx AG | 59 | |
| MBA MBA | Superior Plus Corp | 70 | |
| Steven Rales | Danaher | 72 | |
| Ingrid Engstrom | SIVERS SEMICONDUCTORS AB | 59 | |
| Christopher Lohmann | Talanx AG | 55 | |
| Sven Pettersson | SIVERS SEMICONDUCTORS AB | 60 | |
| Mitchell Rales | Danaher | 66 | |
| Pal Kildemo | Norsk Hydro ASA | 39 | |
| Christopher Bouda | Danaher | N/A | |
| John Bedford | Danaher | N/A | |
| CCLP CMA | Superior Plus Corp | 62 | |
| Torsten Leue | Talanx AG | 57 | |
Management Performance
| Return On Equity | 1.05 | |||
| Return On Asset | 0.22 |
IDEXX Laboratories Leadership Team
Elected by the shareholders, the IDEXX Laboratories' board of directors comprises two types of representatives: IDEXX Laboratories inside directors who are chosen from within the company, and outside directors, selected externally and held independent of IDEXX. The board's role is to monitor IDEXX Laboratories' management team and ensure that shareholders' interests are well served. IDEXX Laboratories' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, IDEXX Laboratories' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sharon Underberg, Gen VP | ||
| Ken Grady, VP Officer | ||
| Jonathan Mazelsky, CEO Pres | ||
| Nimrata PE, Ex Operations | ||
| Martin Smith, Ex CTO | ||
| James Polewaczyk, Ex Officer | ||
| Michael Lane, Ex Technology | ||
| John Hart, VP Operations | ||
| Jeffery Chadbourne, Director Reporting | ||
| Brian McKeon, Ex CFO |
IDEXX Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is IDEXX Laboratories a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 1.05 | |||
| Return On Asset | 0.22 | |||
| Profit Margin | 0.20 % | |||
| Operating Margin | 0.27 % | |||
| Current Valuation | 35.12 B | |||
| Shares Outstanding | 82.9 M | |||
| Shares Owned By Insiders | 0.39 % | |||
| Shares Owned By Institutions | 92.77 % | |||
| Price To Earning | 57.45 X | |||
| Price To Book | 75.09 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in IDEXX Stock
When determining whether IDEXX Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IDEXX Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Idexx Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Idexx Laboratories Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.